These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients. Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy in lymphoma. Alexanian R Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397 [TBL] [Abstract][Full Text] [Related]
12. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy. Alexanian R; Migliore PJ J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404 [No Abstract] [Full Text] [Related]
13. Significance of M-components in plasma cell myeloma and related disorders. Kano T Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555 [No Abstract] [Full Text] [Related]
14. [2 new cases of initial or secondarily non-excreting plasma cell myelomas]. Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504 [No Abstract] [Full Text] [Related]
15. Treatment of plasma cell myeloma with cytotoxic agents. Bergsagel DE; Pruzanski W Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363 [TBL] [Abstract][Full Text] [Related]
16. The behavior of immunoglobulin in monoclonal gammopathies and their classification and pathogenesis. Kano T Tohoku J Exp Med; 1970 Dec; 102(4):369-401. PubMed ID: 4102668 [No Abstract] [Full Text] [Related]
17. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741 [TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma without initial paraproteins. Kim I; Harley JB; Weksler B Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526 [No Abstract] [Full Text] [Related]
19. [Silent onset of multiple myeloma. How to diagnosis and when to treat?]. Bartl R Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250 [No Abstract] [Full Text] [Related]
20. Hypoalbuminemia in patients with multiple myeloma. Chen YH; Magalhaes MC Arch Intern Med; 1990 Mar; 150(3):605-10. PubMed ID: 2310279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]